SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse Hamburg
Börse Börse Hamburg
ISIN DE000BAY0017
EUR
  • BAYER AG NA O.N.
    Börse Börse Hamburg
    ISIN DE000BAY0017 WKN: BAY001
    Symbol BAYN
    EUR
  • BAYER AG
    Börse Xetra Frankfurt
    ISIN XS2199266003 WKN: 879501
    Symbol BAYN
    EUR
  • Bayer
    Börse Börse Frankfurt
    ISIN US0727303028 WKN: 879501
    Symbol BAYA
    EUR
  • BAYER AG NA O.N.
    Börse Börse München
    ISIN XS2199266268
    Symbol BAYN
    EUR
  • Bayer
    Börse Xetra Frankfurt
    Symbol BAYN
    EUR
  • BAYER AG-REG
    Börse Börse Stuttgart
    Symbol BAYN
    EUR
  • BAYER AG-REG
    Börse Quotrix System der Börse Düsseldorf
    Symbol BAYN
    EUR
  • BAYER AG-SPONSORED ADR
    Börse Gettex System der Börse München
    Symbol BAYA
    EUR
  • BAYER AG-REG
    Börse Gettex System der Börse München
    Symbol BAYN
    EUR
  • BAYER AG-REG
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol BAYN
    EUR
  • BAYER AG-REG
    Börse Börse Düsseldorf
    Symbol BAYN
    EUR
  • BAYER AG
    Börse Börse München
    ISIN DE000BAY0017
  • BAYER AG-SPONSORED ADR
    Börse Börse Stuttgart
    Symbol BAYA
    EUR
  • Bayer
    Börse Amerikanscher Freiverkehr OTC oder "Pink Sheets"
    ISIN DE000BAY0017 WKN:
    Symbol BAYN.GY
  • Bayer
    Börse Amerikanscher Freiverkehr OTC oder "Pink Sheets"
    ISIN DE000BAY0017 WKN: BAY001
    Symbol BAYN
  • Bayer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    Symbol BAYN.GY
    MXN
  • ISIN DE000A11QR73
    MXN
  • Symbol BAYN
    EUR
  • ISIN DE000BAY0017 WKN: BAY001
    Symbol BAYN
  • USD
  • USD
  • BAYER AG
    Börse Bolsa de Comercio de Buenos Aires
  • Symbol BAYA
  • EUR
ISIN DE000BAY0017
WKN BAY001
Symbol BAYN
Währung EUR
Börse Börse Hamburg Zeitzone: America/New_York
Marktkapitalisierung 25.008.341.140 (+- 89%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

2.767.000.000 oder 47.249.682.280

Mitarbeiter 100.029 (+- 1%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

100.618 oder 99.439 Mitarbeiter

Anzahl Aktien 982.424.000
KGV 17.5

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Bayer abonniert.

Aktionärsstruktur der Bayer

271 News & Informationen zur Bayer Aktie

  • Monsanto: Nächster Milliarden-Schock bei Bayer
    finance-magazin.de

    Monsanto: Nächster Milliarden-Schock bei Bayer

    Für künftige Glyphosat-Klagen stellt Bayer weitere 4,5 Milliarden Dollar zurück. Die Monsanto-Rechnung droht den freien Cashflow von drei Jahren auszuradieren.

  • Fears Nachawati Trial Lawyers Challenge Bayer AG's Latest Bid To Reduce Weed Killer Liabilities
    thestreet.com

    Fears Nachawati Trial Lawyers Challenge Bayer AG's Latest Bid To Reduce Weed Killer Liabilities

    DALLAS, July 29, 2021 /PRNewswire/ — The latest legal maneuver designed to help Bayer AG circumvent its legal responsibility to cancer victims exposed to the

  • Bayer Plans for Roundup Litigation Claims Rising by $4.5 Billion
    online.wsj.com

    Bayer Plans for Roundup Litigation Claims Rising by $4.5 Billion

    The German company is setting aside additional funds on top of its pledged $11.6 billion to resolve litigation alleging its weedkiller causes cancer.

  • Bayer posts extra $4.5 billion provision for Roundup litigation By Reuters
    investing.com

    Bayer posts extra $4.5 billion provision for Roundup litigation By Reuters

    Bayer posts extra $4.5 billion provision for Roundup litigation

  • Monoclonal Antibodies Market to Reach $390.58 Bn, Globally at 10.2% CAGR by 2030: Says AMR
    prnewswire.com

    Monoclonal Antibodies Market to Reach $390.58 Bn, Globally at 10.2% CAGR by 2030: Says AMR

    /PRNewswire/ — According to the report the, global monoclonal antibodies market was pegged at $146.64 billion in 2020 and is estimated to reach $390.58…

  • Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, July 27, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global polycythemia vera therapeutics market is estimated to be…

  • Lawn and Garden Consumables Market Size to Reach $26.3 Billion by 2030 | CAGR: 4.6%: AMR
    globenewswire.com

    Lawn and Garden Consumables Market Size to Reach $26.3 Billion by 2030 | CAGR: 4.6%: AMR

    Rise in trend toward landscaping, surge in adoption of organic farming, and increase in the number of commercial and residential projects drive the growth…

  • Seed Treatment Market Was Worth $6 Billion In 2020: P&S Intelligence
    thestreet.com

    Seed Treatment Market Was Worth $6 Billion In 2020: P&S Intelligence

    NEW YORK, July 26, 2021 /PRNewswire/ — Seed treatment activities are picking up around the world, as the pressure on the agrarian community is mounting due to

  • Seed Treatment Market Was Worth $6 Billion in 2020: P&S Intelligence
    prnewswire.com

    Seed Treatment Market Was Worth $6 Billion in 2020: P&S Intelligence

    /PRNewswire/ — Seed treatment activities are picking up around the world, as the pressure on the agrarian community is mounting due to the booming population….

  • Cosmetic Chemicals Market Reached $20 Billion Revenue in 2020: P&S Intelligence
    prnewswire.com

    Cosmetic Chemicals Market Reached $20 Billion Revenue in 2020: P&S Intelligence

    /PRNewswire/ — The booming entertainment and fashion industries in both developing and developed countries such as the U.S., France, South Korea, and India,…

  • Global Contrast Injectors Market Growth In Health Care Equipment Industry | Emerging Trends, Company Risk, And Key Executives | Technavio
    thestreet.com

    Global Contrast Injectors Market Growth In Health Care Equipment Industry | Emerging Trends, Company Risk, And Key Executives | Technavio

    NEW YORK, July 23, 2021 /PRNewswire/ —

    The contrast injectors market is poised to grow by USD 578.41 million during 2021-2025, progressing at a CAGR

  • Global Companion Animal Specialty Drugs Market Growth Analysis in Pharmaceuticals Industry | Discover Company Insights in Technavio
    markets.businessinsider.com

    Global Companion Animal Specialty Drugs Market Growth Analysis in Pharmaceuticals Industry | Discover Company Insights in Technavio

    NEW YORK, July 22, 2021 /PRNewswire/ — Technavio's latest report on the companion animal specialty drugs market projects a growth of USD 2.80 bil…

  • Global Companion Animal Specialty Drugs Market Growth Analysis in Pharmaceuticals Industry | Discover Company Insights in Technavio
    prnewswire.com

    Global Companion Animal Specialty Drugs Market Growth Analysis in Pharmaceuticals Industry | Discover Company Insights in Technavio

    /PRNewswire/ — Technavio's latest report on the companion animal specialty drugs market projects a growth of USD 2.80 billion, registering a CAGR of 5.20%…

  • WPP Pulls Out of Facebook’s Media Agency Review
    online.wsj.com

    WPP Pulls Out of Facebook’s Media Agency Review

    Rival advertising firms Dentsu Inc., Havas Group and Publicis Groupe SA are still competing for the highly sought after account, which includes ad spending that could amount to more than $1 billion, according to people familiar with the matter.

  • 10 Stocks with Over 10 Years of Dividend Increases
    insidermonkey.com

    10 Stocks with Over 10 Years of Dividend Increases

    In this article, we will be looking at 10 stocks with over 10 years of dividend increases. If you want to skip our detailed analysis of these companies…

  • Bayer Aktiengesellschaft (BAYRY) Upgraded to Buy: Here's What You Should Know
    zacks.com

    Bayer Aktiengesellschaft (BAYRY) Upgraded to Buy: Here's What You Should Know

    Bayer Aktiengesellschaft (BAYRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

  • Global Disposable Medical Supplies Market (2020 To 2030) - By Product Type, Raw Material, Application, End-user And Region
    thestreet.com

    Global Disposable Medical Supplies Market (2020 To 2030) – By Product Type, Raw Material, Application, End-user And Region

    DUBLIN, July 22, 2021 /PRNewswire/ — The “Global Disposable Medical Supplies Market 2020-2030 by Product Type, Raw Material, Application, End User, and

  • Global Telemedicine Market Market Report 2021-21026 with Analysis of CEVA, Inc, Eli Lilly and Co, Bayer AG, Merck & Co, Teladoc Health, Inc.
    prnewswire.com

    Global Telemedicine Market Market Report 2021-21026 with Analysis of CEVA, Inc, Eli Lilly and Co, Bayer AG, Merck & Co, Teladoc Health, Inc.

    /PRNewswire/ — The “Telemedicine Market, Global Forecast Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Financial Insight” report…

  • Global Telemedicine Market Market Report 2021-21026 With Analysis Of CEVA, Inc, Eli Lilly And Co, Bayer AG, Merck & Co, Teladoc Health, Inc.
    thestreet.com

    Global Telemedicine Market Market Report 2021-21026 With Analysis Of CEVA, Inc, Eli Lilly And Co, Bayer AG, Merck & Co, Teladoc Health, Inc.

    DUBLIN, July 21, 2021 /PRNewswire/ — The “Telemedicine Market, Global Forecast Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview,

  • Tatva Chintan IPO: Why it attracted the second-highest subscription level among issues in 2021
    moneycontrol.com

    Tatva Chintan IPO: Why it attracted the second-highest subscription level among issues in 2021

    Most companies are capitalising on suitable market conditions to raise equity capital at premium valuations. Tatva Chintan was no exception and investors bid for 180 times the shares that the company offered.

  • Global Castrate Resistant Prostate Cancer (CRPC) Market to Surpass US$ 16.4 Billion by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    Global Castrate Resistant Prostate Cancer (CRPC) Market to Surpass US$ 16.4 Billion by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, July 20, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global castrate-resistant prostate cancer market is estimated to be…

  • Global Monoclonal Antibodies Market is Expected to Reach $390.58 Billion by 2030: Says AMR
    globenewswire.com

    Global Monoclonal Antibodies Market is Expected to Reach $390.58 Billion by 2030: Says AMR

    Increase in prevalence of various cancer types, rise in demand for cost-efficient biosimilar monoclonal antibodies, and upsurge in likelihood of epidemic…

  • Diabetic Nephropathy Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Analysis, Forecast Report
    globenewswire.com

    Diabetic Nephropathy Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Analysis, Forecast Report

    Top Players Covered in the Diabetic Nephropathy Market Research Report are Merck & Co., Inc., Abbott, Pfizer Inc., Siemens, Novartis AG, GENERAL ELECTRIC…

  • Medizintechnik: B. Braun setzt auf Datenintegration
    cio.de

    Medizintechnik: B. Braun setzt auf Datenintegration

    Mit einer Plattform für die Datenintegration verbessert B. Braun Melsungen die Vernetzung mit seinen Partnern.

  • GR Infraprojects, Clean Science trade at over 60% premium in grey market, ahead of listing
    moneycontrol.com

    GR Infraprojects, Clean Science trade at over 60% premium in grey market, ahead of listing

    Both companies will list their equity shares on the bourses on July 19. So far 25 firms closed their IPOs successfully and debuted in the current year 2021.

  • Contrast Media Market worth $5.9 billion by 2026 - Exclusive Report by MarketsandMarkets™
    prnewswire.com

    Contrast Media Market worth $5.9 billion by 2026 – Exclusive Report by MarketsandMarkets™

    /PRNewswire/ — According to the new market research report “Contrast Media/ Contrast Agent Market by Type (Iodinated Contrast Media), Modality (X-Ray/CT, MRI,…

  • Contrast Media Market worth $5.9 billion by 2026
    prnewswire.com

    Contrast Media Market worth $5.9 billion by 2026

    /PRNewswire/ — According to the new market research report “Contrast Media/ Contrast Agent Market by Type (Iodinated Contrast Media), Modality (X-Ray/CT, MRI,…

  • GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
    forbes.com

    GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022

    The company operates in three major business segments, Pharmaceuticals, Vaccines and Consumer Healthcare.

  • Tatva Chintan Pharma Chem IPO opens tomorrow, 10 key things to know about the issue
    moneycontrol.com

    Tatva Chintan Pharma Chem IPO opens tomorrow, 10 key things to know about the issue

    Promoters held 1,61,75,850 equity shares in aggregate, representing 80.53 percent of total paid up equity of Tatva Chintan.

  • DGAP-PVR : Bayer Aktiengesellschaft: Release -2-
    marketscreener.com

  • DGAP-PVR : Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the...
    marketscreener.com

    DGAP-PVR : Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

    DGAP Voting Rights Announcement: Bayer Aktiengesellschaft
    Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act]
    with the objective of… | July 15, 2021

  • Ada expands its global leadership team to help drive company's rapid growth
    prnewswire.com

    Ada expands its global leadership team to help drive company's rapid growth

    /PRNewswire/ — Ada, the global health company, today announces the appointment of digital transformation veterans Gülsah Wilke, Torsten Schero and Vanessa…

  • West Syndrome Market is Projected to Rising at a Steady Growth at a 5.8% CAGR During the Study Period [2018-2030], Analyses DelveInsight
    markets.businessinsider.com

    West Syndrome Market is Projected to Rising at a Steady Growth at a 5.8% CAGR During the Study Period [2018-2030], Analyses DelveInsight

    LAS VEGAS, July 14, 2021 /PRNewswire/ — DelveInsight's 'West Syndrome Market' report provides a thorough comprehension of the West Syndrome histo…

  • West Syndrome Market is Projected to Rising at a Steady Growth at a 5.8% CAGR During the Study Period [2018-2030], Analyses DelveInsight
    prnewswire.com

    West Syndrome Market is Projected to Rising at a Steady Growth at a 5.8% CAGR During the Study Period [2018-2030], Analyses DelveInsight

    /PRNewswire/ — DelveInsight's

  • Global Rodenticides Market to Reach $7.1 Billion by 2026
    prnewswire.com

    Global Rodenticides Market to Reach $7.1 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • U.S. OTC Drugs Market Size to Reach Revenues USD 43.18 Billion by 2026
    prnewswire.com

    U.S. OTC Drugs Market Size to Reach Revenues USD 43.18 Billion by 2026

    /PRNewswire/ — In-depth analysis and data-driven insights on the impact of COVID-19 included in this U.S. OTC drugs market report. The U.S. OTC drugs market…

  • Tatva Chintan Pharma Chem IPO to open on July 16; price band set at Rs 1,073-1,083
    moneycontrol.com

    Tatva Chintan Pharma Chem IPO to open on July 16; price band set at Rs 1,073-1,083

    The company plans to raise Rs 500 crore through IPO which comprises a fresh issue of Rs 225 crore and an offer for sale of Rs 275 crore by existing selling shareholders.

  • Worldwide Artificial Tears Industry to 2028 - Increasing Number of Industrial Developments Presents Opportunities
    prnewswire.com

    Worldwide Artificial Tears Industry to 2028 – Increasing Number of Industrial Developments Presents Opportunities

    /PRNewswire/ — The “Artificial Tears Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Type, Delivery Mode, and Application” report has been…

  • Active Pharmaceutical Ingredients Market Worth USD 312 Billion by 2028 at 6.2% CAGR - Report by Market Research Future (MRFR)
    globenewswire.com

    Active Pharmaceutical Ingredients Market Worth USD 312 Billion by 2028 at 6.2% CAGR – Report by Market Research Future (MRFR)

    Active Pharmaceutical Ingredients Market Insights and Industry Analysis by Type of Synthesis (Biotech and Synthetic), By Molecules (Large Molecule and…

  • Global Anticoagulants Market (2021 to 2026) - by Drug Class, Route of Administration and Geography
    markets.businessinsider.com

    Global Anticoagulants Market (2021 to 2026) – by Drug Class, Route of Administration and Geography

    DUBLIN, July 7, 2021 /PRNewswire/ — The 'Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impac…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Bayer Aktie

Das Unternehmen Bayer aus Deutschland beschäftigt 100.029 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Pharmazeutika, Spezialchemie, LifeScience, Kunststoffe, Medizinische Produkte / Medizintechnik, Chemie, Biotechnologie, Pharma tätig.

Tochterunternehmen von Bayer sind: Bayer Cropscience Ltd/India, Bayer CropScience Limited.

Bayer ist in mehr als 82 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Indxx Global Agriculture ETF gewichtet Bayer mit 9,59% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Bayer Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Bayer am höchsten gewichtet ist Insgesamt in 82 ETFs enthalten

Dir gefallen die Informationen zu Bayer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Bayer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Bayer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Bayer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic